Plasma Protein Therapeutics Association
about PPTA
The Plasma Protein Therapeutics Association (PPTA) is a key player in the plasma industry, with an extensive network of human plasma collection centers and manufacturers. Collaborating with numerous key stakeholders and policymakers to establish rightful standards and programs for donors and patients is at the core of our work.
Why you should donate plasma
Plasma-derived medicines are often the only therapies for many rare and chronic diseases. By becoming a donor, you increase the chances of regular access to plasma medicines for those in need, contributing to the improvement of health outcomes for patients.
Resource centER
Learn more about our work through the material in our resource center.
Media
Stay up to date with the key developments and issues discussed by our stakeholders, members, and patients by taking a look at our available media resources.
Interview with Irene Saugar Gómez, Ph.D., Quality Assessor of biological human medicinal products with the Spanish Agency of Medicines and Medical Devices
PPTA President and CEO Anita Brikman speaks with Grifols Egypt CEO Dr. Magdy Amin
Oksana Muliarchuk - Director of a Ukrainian-Based Network of Plasma Centers
Thomas Kreil, Winner of the Hilfenaus Award
Watch our interview with Prof. Richard Knight as he shares valuable perspectives on immunoglobulins
Patient Stories presented by PPTA
PPTA New Website and Brand Launch
The Brussels Times Hosts Event at the European Parliament
Take a tour of a plasma donation center in Frankfurt, Germany
The need for a policy change – Plasma donation
2022 International Plasma Protein Congress (IPPC): Day One
2022 International Plasma Protein Congress (IPPC): Day Two
Differentiating Plasma from Blood
U.S. Roundtable on Immunoglobulin Use
EU BTC revision – The socioeconomic benefits of plasma-derived medicines
Why is Donating Plasma Important?
Strengthening the EU Blood Directive for patients who need plasma-derived medicines
Meet Amber, a Teacher and Dedicated Plasma Donor
Europe needs to collect more plasma – Improving patient access to plasma-derived medicines
EU BTC revision – Facts about compensating plasma donors
April 2021 Online Roundtable hosted by MEP Sirpa Pietikäinen (EPP, Finland)
Highlights from the April 2021 Online Roundtable hosted by MEP Sirpa Pietikäinen (EPP, Finland)
“Introduction to the Global Journey of Plasma" webinar
Highlights from the EP roundtable event “Ensuring Appropriate Patient Access to PDMPs”
Presentation of the 2020 Joachim Hilfenhaus Award
Presentation of the 2020 Robert W. Reilly Award
Plasma: An Overview
Experts on Coronavirus: The Virus, The Disease, Prevention and Treatment
Patient Perspectives on COVID-19 and Access to Care
Combating COVID-19 Industry Spotlight: Kedrion
Keynote Address – Stella Kyriakides, European Commissioner for Health and Food Safety
Keynote Address – Admiral Brett Giroir, MD, U.S. HHS Assistant Secretary for Health
Plasma 101
Welcome to the Global Plasma Summit
Combating COVID-19 Industry Spotlight: CoVIg-19 Plasma Alliance
Combating COVID-19 Industry Spotlight: Emergent
Combating COVID-19 Industry Spotlight: Grifols
Spotlight on Plasma Part One: Together We Are Stronger
Ensuring Appropriate Patient Access to Plasma-Derived Medicinal Products
PPTA webinar on unique patient access challenges to plasma-derived medicinal products in COVID times link
Thank you, plasma donors!
From PPTA: "Thank you, plasma donors!"
Prof. Lieven Annemans Speaks about the Value of Plasma-Derived Therapies
The Power of Plasma Donation - Hungarian
The Power of Plasma Donation - Czech
The Power of Plasma Donation - Spanish
The Power of Plasma Donation - German
The Power of Plasma Donation Animation - English
Plasma Protein Forum Prepares to “Taking Steps Toward a Better Tomorrow”
Plasma Protein Forum Prepares to “Taking Steps Toward a Better Tomorrow”
Sharing the Lifesaving Impact of Plasma Donation During International Plasma Awareness Week 2024
Sharing the Lifesaving Impact of Plasma Donation During International Plasma Awareness Week 2024
Monkeypox Virus and Plasma-derived Medicinal Products
Monkeypox Virus and Plasma-derived Medicinal Products
PPTA Welcomes EMA Regulatory Update on vCJD
PPTA Welcomes EMA Regulatory Update on vCJD
PPTA Welcomes Sharon Pearce as New Vice President, Lead of Government Affairs
PPTA Welcomes Sharon Pearce as New Vice President, Lead of Government Affairs
PPTA Regards SoHO Adoption a Step Forward to Strengthen Donor Protection and Plasma Supply in the EU
PPTA Regards SoHO Adoption a Step Forward to Strengthen Donor Protection and Plasma Supply in the EU
Dr. Charlotte Cunningham-Rundles Wins 2024 Joachim Hilfenhaus Award for Immunology Excellence
Dr. Charlotte Cunningham-Rundles Wins 2024 Joachim Hilfenhaus Award for Immunology Excellence
PPTA Responds to SoHO Regulation Compromise
PPTA Responds to SoHO Regulation Compromise
PPTA’s New Staff Members Aim to Further Plasma Sector Innovation and Advocacy
PPTA’s New Staff Members Aim to Further Plasma Sector Innovation and Advocacy
Summary of the PPTA/FDA Liaison Meeting (November 8, 2023)
Summary of the PPTA/FDA Liaison Meeting (November 8, 2023)
PPTA Statement on Issuance of the EU Critical Medicines List
PPTA Statement on Issuance of the EU Critical Medicines List
PPTA Statement and Reflection on the Quebec Biovigilance Committee’s 8th Biovigilance Forum
PPTA Statement and Reflection on the Quebec Biovigilance Committee’s 8th Biovigilance Forum
PPTA Statement on the Council’s negotiating mandate on the SoHO Regulation
PPTA Statement on the Council’s negotiating mandate on the SoHO Regulation
European Parliament Misses Opportunity to Increase Plasma Collection in Europe to Make Essential Medicines
European Parliament Misses Opportunity to Increase Plasma Collection in Europe to Make Essential Medicines
Study Confirms that Frequency of Source Plasma Donation as Regulated by U.S. FDA Does Not Impair Donor Health and Well-Being
Study Confirms that Frequency of Source Plasma Donation as Regulated by U.S. FDA Does Not Impair Donor Health and Well-Being
PPTA Press Release on the EU Parliament's ENVI Committee Vote on the SoHO Regulation
PPTA Press Release on the EU Parliament's ENVI Committee Vote on the SoHO Regulation
PPTA Statement on the Revision of the General EU Pharmaceutical Legislation
PPTA Statement on the Revision of the General EU Pharmaceutical Legislation
Announcing PPTA’s New Global Chair
Announcing PPTA’s New Global Chair
Monkeypox Virus and Plasma Protein Therapies
Monkeypox Virus and Plasma Protein Therapies
PPTA Executive Summary of FDA’s U.S. Immunoglobulin Utilization Study Report
PPTA Executive Summary of FDA’s U.S. Immunoglobulin Utilization Study Report
PPTA Statement on Review of Donor Blood Pressure Requirements
PPTA Statement on Review of Donor Blood Pressure Requirements
PPTA Statement on Review of Donor Weight Loss Monitoring
PPTA Statement on Review of Donor Weight Loss Monitoring
Statement on Update on Safety of Albumin
Statement on Update on Safety of Albumin
PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses
PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses
Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus
Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus
Human Parvovirus PARV4 and plasma protein therapies
Human Parvovirus PARV4 and plasma protein therapies
Ebola Virus and Plasma Protein Therapies
Ebola Virus and Plasma Protein Therapies
PPTA Statement on MSM Donor Policy
PPTA Statement on MSM Donor Policy
Zika Virus and Plasma Protein Therapies
Zika Virus and Plasma Protein Therapies
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)
PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”
PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies
A Note to U.S. Plasma Donors on the Spread of Coronavirus
A Note to U.S. Plasma Donors on the Spread of Coronavirus
PPTA Responds to The Guardian Article
PPTA Responds to The Guardian Article
PPTA Statement on FDA Guidance Documents
PPTA Statement on FDA Guidance Documents
PPTA Repeats Appeals for Plasma Donations
PPTA Repeats Appeals for Plasma Donations
New York and California recognize the importance of plasma donation
New York and California recognize the importance of plasma donation
Plasma Donors Should be Celebrated, not Denigrated
Plasma Donors Should be Celebrated, not Denigrated
PPTA Statement on the Urgent Need for Plasma Donation
PPTA Statement on the Urgent Need for Plasma Donation
PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act
PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act
Yes, you can donate source plasma after getting the COVID vaccine
Yes, you can donate source plasma after getting the COVID vaccine
PPTA Statement on Immunoglobulin Use to Meet Clinical Need
PPTA Statement on Immunoglobulin Use to Meet Clinical Need
Human Plasma Donations Remain Important During COVID-19 Pandemic
Human Plasma Donations Remain Important During COVID-19 Pandemic
New position statement by CHMP regarding donor deferral criteria for sexual behaviour helps assessment of PMFs
New position statement by CHMP regarding donor deferral criteria for sexual behaviour helps assessment of PMFs
Study Shows Immunoglobulin Therapy is “Critical and Cost-Effective” in Treating COVID
Study Shows Immunoglobulin Therapy is “Critical and Cost-Effective” in Treating COVID
PPTA Responds to ProPublica Article
PPTA Responds to ProPublica Article
Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives
Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives
PPTA Disagrees with Ruling from Romanian Competition Council
PPTA Disagrees with Ruling from Romanian Competition Council
PPTA Leadership Update – Amy Efantis
PPTA Leadership Update – Amy Efantis
PPTA Statement on the Ukraine Crisis
PPTA Statement on the Ukraine Crisis
PPTA Statement on Report of ENVI Rapporteur for the SoHO Regulation
PPTA Statement on Report of ENVI Rapporteur for the SoHO Regulation
PPTA Statement on the draft EU Substances of Human Origin Regulation
PPTA Statement on the draft EU Substances of Human Origin Regulation
PPTA Recognizes First Plasma Collection Centers Certified in Hungary
PPTA Recognizes First Plasma Collection Centers Certified in Hungary
PPTA Recognizes World Hemophilia Day 2014
PPTA Recognizes World Hemophilia Day 2014
International Plasma Awareness Week to Celebrate Donors and Spotlight Rare Diseases
International Plasma Awareness Week to Celebrate Donors and Spotlight Rare Diseases
Ensuring Access to Medicines for Patients
Ensuring Access to Medicines for Patients
PPTA Recognizes 8th Annual International Rare Disease Day
PPTA Recognizes 8th Annual International Rare Disease Day
PPTA Recognizes World Hemophilia Day–April 17, 2015
PPTA Recognizes World Hemophilia Day–April 17, 2015
Alabama Lowers Minimum Donation Age to 18
Alabama Lowers Minimum Donation Age to 18
PPTA Recognizes Essential Contributions of Plasma Donors
PPTA Recognizes Essential Contributions of Plasma Donors
PPTA Names Amy Efantis President & CEO
PPTA Names Amy Efantis President & CEO
Plasma-Derived Therapies Provide Significant Health Value Gain
Plasma-Derived Therapies Provide Significant Health Value Gain
EU Health Commissioner Says Plasma Donation is “More Important Than Ever”
EU Health Commissioner Says Plasma Donation is “More Important Than Ever”
International Plasma Awareness Week 2020: Be a Hero, Donate Plasma Today
International Plasma Awareness Week 2020: Be a Hero, Donate Plasma Today
Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma
Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma
Lifting of long-time ban on use of UK plasma for manufacturing of immunoglobulins will help patients
Lifting of long-time ban on use of UK plasma for manufacturing of immunoglobulins will help patients
EU Health Commissioner says plasma donation plays a vital role
EU Health Commissioner says plasma donation plays a vital role
International Plasma Awareness Week 2021: Donate Plasma. Save Lives.
International Plasma Awareness Week 2021: Donate Plasma. Save Lives.
Calling on EU Policymakers to Increase Plasma Donations
Calling on EU Policymakers to Increase Plasma Donations
Adoption of the EP report “EU Pharmaceutical Strategy”
Adoption of the EP report “EU Pharmaceutical Strategy”
Plasma is Life podcast series episode 6: Peter Jaworski, Georgetown University
Plasma is Life podcast series episode 5: Nancy Di Salvo, GBS|CIDP Foundation
Plasma is Life podcast series episode 4: Vicki & Fred Modell, Co-Founders, Jeffrey Modell Foundation
Plasma is Life podcast series episode 2: U.S. Election 2020 Wrap-Up
Share Your #IPAW2024 Feedback
Share Your #IPAW2024 Feedback
IPAW Reflections: Words of Appreciation for the Lifesaving Impact of Plasma Donors
IPAW Reflections: Words of Appreciation for the Lifesaving Impact of Plasma Donors
Voices of Health Professionals in Treating Patients with Plasma-Derived Medicines
Voices of Health Professionals in Treating Patients with Plasma-Derived Medicines
IPAW In Focus: Prioritizing Donor Safety
IPAW In Focus: Prioritizing Donor Safety
Putting Advocacy In Action During IPAW and Beyond
Putting Advocacy In Action During IPAW and Beyond
Access to Plasma-Derived Medicines: A Lifesaving Resource for Patients
Access to Plasma-Derived Medicines: A Lifesaving Resource for Patients
Share Powerful Stories During #IPAW2024
Share Powerful Stories During #IPAW2024
Decorate Your Space for #IPAW2024!
Decorate Your Space for #IPAW2024!
Stay Connected on Social Media During #IPAW2024
Stay Connected on Social Media During #IPAW2024
Visit PlasmaWeek.org for Free IPAW Resources and More!
Visit PlasmaWeek.org for Free IPAW Resources and More!
Navigating Challenges and Opportunities in the Plasma Protein Therapeutics Industry: A Discussion with Anita Brikman and Giles Platford
Navigating Challenges and Opportunities in the Plasma Protein Therapeutics Industry: A Discussion with Anita Brikman and Giles Platford
A Mid-Year Message from PPTA President and CEO Anita Brikman
A Mid-Year Message from PPTA President and CEO Anita Brikman
Sharing the Power of Plasma on Capitol Hill
Sharing the Power of Plasma on Capitol Hill
From Patient to Provider: Laura’s Story
From Patient to Provider: Laura’s Story
2023 Annual Report
2023 Annual Report
PPTA Unveils Program for IPPC 2024
PPTA Unveils Program for IPPC 2024
A Story of Alpha-1 Antitrypsin Deficiency: Dan Coffin's Journey of Finding Hope, One Plasma Donation at a Time
A Story of Alpha-1 Antitrypsin Deficiency: Dan Coffin's Journey of Finding Hope, One Plasma Donation at a Time
Stepping Inside a Plasma Fractionation Plant: How Human Plasma Becomes Life-Saving Medicine
Stepping Inside a Plasma Fractionation Plant: How Human Plasma Becomes Life-Saving Medicine
Events
Alpha-1 Awareness Month
Alpha-1 Awareness Month
Join PPTA
Become a member of PPTA! PPTA engages with stakeholders to establish and improve regulations and policies that affect the sector.
By being a member of our industry-leading association, you can work closely with influential partners, enjoy numerous benefits and access useful resources.